SCHEMBL14413882

SCHEMBL14413882

CSc1ccc(NC(=O)N2CCC(C)CC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.64
▸ LMNA P02545 5/20 0.62
▸ EPHX2 P34913 1/20 0.60
▸ MAPT P10636 6/20 0.55
▸ NPC1 O15118 3/20 0.55
▸ THRB P10828 2/20 0.55
▸ KDM4E B2RXH2 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ RECQL P46063 1/20 0.50
▸ STAT3 P40763 1/20 0.50
▸ ALOX5 P09917 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8361593 0.84 RAB9A (0.66) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL12994636 0.83 TSHR (0.71) ALDH1A1LMNAEPHX2MAPTNPC1
SCHEMBL11839197 0.82 SMN1; SMN2 (0.68) ALDH1A1LMNAEPHX2MAPTNPC1
SCHEMBL11837576 0.82 ALOX5 (0.69) ALDH1A1LMNAEPHX2MAPTNPC1
SCHEMBL11833345 0.81 LMNA (0.79) ALDH1A1LMNAEPHX2MAPTNPC1
SCHEMBL22217937 0.81 GAA (0.68) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL12668447 0.81 LMNA (0.64) ALDH1A1LMNAEPHX2MAPTNPC1
SCHEMBL13450335 0.79 MEN1 (0.68) ALDH1A1LMNAEPHX2MAPTNPC1
SCHEMBL5912255 0.79 TRPV1 (0.70) ALDH1A1LMNAMAPTNPC1KDM4E
SCHEMBL14393776 0.78 EPHX2 (0.70) ALDH1A1LMNAEPHX2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007106706-A1 CYCLIC UREA COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS EFFECTIVE FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-09-20 — — WO disclosed
Send feedback